BI
Bionoid Pharma, Inc.
BINP · OTC
$0.02 -46.95% (-$0.02)
Piotroski F-Score Weak
1/9Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
50 /100
Moderate Beta -4.66x
EPS volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BINP
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Patricia Colvin
Employees
5
Headquarters
Beverly Hills